This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...